Telemedicine: An Opportunity or a Challenge?
While medical cannabis is becoming increasingly destigmatized, some telemedicine services have recently come under scrutiny. In particular, concerns have been raised about the practice of issuing prescriptions based solely on an online questionnaire without direct doctor-patient interaction, raising fears of misuse. However, it is important to recognize that telemedicine has become an integral part of healthcare in many areas, offering enormous benefits to countless patients.
Telemedicine allows for quick and convenient medical consultations — especially in rural regions where specialist shortages are a pressing issue. For chronically ill patients who rely on continuous treatment, digital access to healthcare can be a major relief.
At the same time, concerns about compliance with existing regulations and quality assurance are valid. However, rather than questioning telemedicine as a whole, the discussion should focus on how to ensure proper enforcement of existing rules to safeguard both patient protection and the integrity of medical care.
A Balanced Perspective on the Debate
This debate highlights that a targeted regulatory response should not be limited to medical cannabis alone but should consider telemedicine as a healthcare model in general. There are already established legal frameworks, such as the EU Patient Mobility Directive and the Medicinal Products Advertising Act (Heilmittelwerbegesetz – HWG), which set standards for safe and regulated cross-border access to telemedical services.
The concerns surrounding telemedicine demonstrate that new digital healthcare models are not inherently problematic but require clear guidelines to ensure safe and high-quality applications. Medical cannabis is not the only field where telemedical services are playing an increasingly important role—this issue affects the entire healthcare sector.
Regulate Telemedicine Sensibly, Not Demonize It
The political debate should focus on how telemedicine can be responsibly utilized rather than portraying it as a problem in itself.
A rational, solution-oriented discussion is needed—one that involves patients, doctors, and policymakers alike.
Modern, digital healthcare solutions offer substantial benefits—not just for medical cannabis but for numerous other prescription medications.
The key challenge is to strengthen and enforce existing regulations while further developing policies that ensure quality and safety for all patients.
Anything else?
Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to briefing@cansativa.de. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!
We wish you a good read!
Best wishes from both of us,

Jakob Sons
Founder & Managing Director Cansativa

Benedikt Sons
Founder & Managing Director Cansativa


Jakob Sons
Founder & Managing Director Cansativa


Benedikt Sons
Founder & Managing Director Cansativa